Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Immunic, Inc. (IMUX)
A side-by-side comparison of Corbus Pharmaceuticals Holdings, Inc. and Immunic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IMUX
Immunic, Inc.
$7.82HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRBP vs IMUX
growth of $100 · dividends reinvested · last 10yCRBP -97.2% (-30.1%/yr)IMUX -99.7% (-43.5%/yr)CRBP compounded faster over this window
Log scale — wide-divergence pair
CRBP IMUX
CRBP vs IMUX: by the numbers
- •CRBP is the larger company ($107M vs $107M market cap).
Metrics side by side
Valuation
| Metric | CRBP | IMUX |
|---|---|---|
| P/B ratio | 1.05 | 0.83 |
Profitability
| Metric | CRBP | IMUX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -99.67% | -87.45% |
| ROIC | -101.30% | -92.16% |
Growth (annualized)
| Metric | CRBP | IMUX |
|---|---|---|
| Total return CAGR (5Y) | -28.32% | -35.70% |
Frequently asked
- How have CRBP and IMUX total returns compared?
- Over the past 10 years, CRBP delivered -31.74% and IMUX delivered -43.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.